However, this mechanism suggests that hypoxia should benefit all complex I-linked mitochondrial diseases that similarly compromise the rate of catalysis, not be specific to a particular subset (including the ndufs4−/− family) or a specific genetic background (or species). This evidence concerns the gene NDUFS4 and mitochondrial disease.